Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
01 1Bachem AG
02 3Aspen Oss B.V.
03 1Ambiopharm, Inc.
04 1Aurobindo Pharma Limited
05 1BCN PEPTIDES SA
06 1Darmerica, LLC
07 13Hemmo Pharmaceuticals Pvt. Ltd
08 1MEDISCA Inc.
09 23Piramal Pharma Limited
10 1PolyPeptide Laboratories, Pvt. Ltd.
11 1Professional Compounding Centers of America
12 1Shanxi Tongda Pharmaceutical Co., Ltd.
13 3Takeda Pharmaceutical Company LTD
14 8Takeda Pharmaceutical Company Limited
15 1Zhejiang Peptites Biotech Co., Ltd.
16 1Zhejiang Supor Pharmaceuticals Co., Ltd
01 2LEUPROLIDE
02 2Leuprolide
03 45Leuprolide Acetate
04 1Leuprorelin
05 11leuprolide acetate
01 2China
02 1India
03 11Japan
04 3Netherlands
05 1Spain
06 2Switzerland
07 39U.S.A
08 1United Kingdom
09 1Blank
Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.
NDC Package Code : 55463-0002
Start Marketing Date : 2001-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aspen API. More than just an API™
NDC Package Code : 60870-0425
Start Marketing Date : 1996-04-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aspen API. More than just an API™
NDC Package Code : 60870-0471
Start Marketing Date : 2014-06-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Aspen API. More than just an API™
NDC Package Code : 60870-0472
Start Marketing Date : 1996-04-19
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11532-1450
Start Marketing Date : 1990-10-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (3.75mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1451
Start Marketing Date : 1989-01-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1452
Start Marketing Date : 1993-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (11.25mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1453
Start Marketing Date : 1993-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (15mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1454
Start Marketing Date : 1993-04-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (7.5mg/mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-1455
Start Marketing Date : 2011-06-17
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION (45mg/1.5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
34
PharmaCompass offers a list of Leuprolide Acetate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leuprolide Acetate manufacturer or Leuprolide Acetate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leuprolide Acetate manufacturer or Leuprolide Acetate supplier.
PharmaCompass also assists you with knowing the Leuprolide Acetate API Price utilized in the formulation of products. Leuprolide Acetate API Price is not always fixed or binding as the Leuprolide Acetate Price is obtained through a variety of data sources. The Leuprolide Acetate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Enantone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Enantone, including repackagers and relabelers. The FDA regulates Enantone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Enantone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Enantone manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Enantone supplier is an individual or a company that provides Enantone active pharmaceutical ingredient (API) or Enantone finished formulations upon request. The Enantone suppliers may include Enantone API manufacturers, exporters, distributors and traders.
click here to find a list of Enantone suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Enantone as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Enantone API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Enantone as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Enantone and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Enantone NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Enantone suppliers with NDC on PharmaCompass.
We have 13 companies offering Enantone
Get in contact with the supplier of your choice:
